Across the recent three months, 6 analysts have shared their insights on Conmed (NYSE:CNMD), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 1 | 1 | 0 | 0 |
Last 30D | 2 | 1 | 1 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Conmed, presenting an average target of $89.5, a high estimate of $107.00, and a low estimate of $71.00. Observing a downward trend, the current average is 7.42% lower than the prior average price target of $96.67.
Investigating Analyst Ratings: An Elaborate Study
The standing...
Login or create a forever free account to read this news
Sign up/Log in